Intra-Arterial Delivery of Cell Therapies for Stroke.
Intra-Arterial Delivery of Cell Therapies for Stroke.
复制标题
DOI:
10.1161/strokeaha.117.018288
复制
发表时间:
2018-05
期刊:
影响因子:
8.3
通讯作者:
Walczak P
中科院分区:
文献类型:
--
作者:
Guzman R;Janowski M;Walczak P
2 Stroke May 2018 so the trophic function of capillaries is maintained. Although some degree of temporary capillary blockage may be tolerated, if a critical threshold is exceeded, this inevitably leads to local hypoxia/ischemia and microembolic lesions. The density of cerebral capillaries varies in different brain structures, with the cortex having≈ 5× the density of the corpus callosum, 11 and in this context, white matter might be more vulnerable to capillary occlusion. During intra-arterial stem cell delivery, relatively large numbers of cells are infused, with the anticipation that they will be captured by the cerebral vasculature; however, the cell load or local pressure disturbances may compromise the safety of this procedure. To date, over 50 intra-arterial cell delivery studies in stroke have been published, and many studies have reported procedure-related complications. Important lessons on safety were learned, and several factors have been identified as critical for the safety of intra-arterial cell delivery. The most important variables that were identified are cell type and size, cell dose, infusion speed, and preservation of arterial blood flow in the feeding vessel during infusion. Other important factors to consider are timing after stroke onset and the anatomic considerations of the target (Figure 1). Comprehensive overview of the experimental conditions is included in Table I in the onlineonly Data Supplement. Details pertaining safety are included in Table II in the online-only Data Supplement.